Japan's Takeda Offers Billions to Settle US Drug Lawsuits

Japan's top drugmaker Takeda Pharmaceutical has offered $2.2 billion to settle U.S. claims linked to its diabetes drug Actos, in what would be one of the biggest U.S. payouts over patient lawsuits. Content Classification:  Curated read more
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.